Uganda receives 19,200 doses of twice-yearly injectable HIV prevention drug, but when and where will it be rolled out?
Uganda has received 19,200 doses of Lenacapavir, a new long-acting HIV prevention drug that is taken only twice a year ...
Uganda has received 19,200 doses of Lenacapavir, a new long-acting HIV prevention drug that is taken only twice a year ...
Uganda’s National Drug Authority (NDA) has approved Lenacapavir, a long-acting HIV prevention injection developed by US pharmaceutical company Gilead Sciences, ...
Minister of Health, Dr Jane Ruth Aceng, has welcomed a landmark global deal that will dramatically slash the cost of ...
The World Health Organization (WHO) has officially recommended the use of a newly approved HIV prevention drug, lenacapavir, marking a ...
Uganda is preparing to roll out Lenacapavir, a revolutionary HIV prevention injection that provides protection for six months and has ...
The US Food and Drug Administration (FDA) has approved lenacapavir for the prevention of HIV, marking a major milestone in ...
A groundbreaking trial called PURPOSE 1 has yielded remarkable results, offering a promising alternative to daily pills for HIV prevention. ...